PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application
Luca Mastracci(Ospedale Policlinico San Martino), Matteo Fassan(University of Padua)
Cited by 41
Related Papers
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Class 1, 2, and 3 <i>BRAF</i> -Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization
|Clinical Cancer Research|2019|107
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence
|Cancers|2021|68
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization
|Cancer Immunology Immunotherapy|2020|25